Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Category: Health product
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 8 of 8 items.
Health Canada warns about certain hand sanitizers that may pose health risks (Part 2 – March 31, 2021 to present)
… hand sanitizers Issue Health products - Product safety COVID What to do Stop using the identified product lots … printed on the label Product recalled by company 2021-04-19 Sani-Derm May contain unacceptable ingredient, ethyl … seek medical help immediately. To help limit the spread of COVID-19, wash your hands often with soap and water for at …
AlertPublic advisory | 2022-07-11
Fraudulent and unauthorized N95 respirators may not protect consumers against COVID-19
… N95 respirators, as they may not protect consumers against COVID-19. What to do: Check whether your N95 respirator has been … stop using it as it may not protect you against COVID-19. What you should do Media enquiries Public enquiries …
AlertPublic advisory | 2020-04-14
Archived - Drug Release Information for the EVRA Transdermal Contraceptive System - For the Public
… Starting date: March 19, 2009 Posting date: March 19, 2009 Type of communication: … RA-19000741 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … Footnote * Birth Control Patch Average Daily Release Rate Janssen-Ortho Inc., in cooperation with Health Canada, is …
AlertHealth professional risk communication | 2009-03-19
Archived – New Safety Information Regarding Intelence (etravirine) and Severe Skin and Hypersensitivity Reactions – For the Public
… Starting date: October 19, 2009 Posting date: October 19, 2009 Type of … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc . Contact the company for a copy of any … Severe Skin and Allergic Reactions Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …
AlertHealth professional risk communication | 2009-10-19
Archived – Medication Errors Involving REMINYL and AMARYL® – Janssen-Ortho Inc. and Aventis Pharma Inc.
… RA-19000210 This is duplicated text of a letter from Janssen-Ortho Inc. and Aventis Pharma Inc. Contact the … and AMARYL ® (glimepiride). Toronto, December 21, 2004 - Janssen-Ortho Inc. and Aventis Pharma Inc., (collectively, … Canada at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Or call toll …
AlertHealth professional risk communication | 2004-12-21
Archived - Association of PREZISTA (darunavir) with hepatotoxicity
… RA-19000676 This is duplicated text of a letter from Janssen-Ortho Inc . Contact the company for a copy of any … and serious liver side effects Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in cooperation with Health … a division of Janssen-Ortho Inc. Drug Safety Department 19 Green Belt Drive Toronto, ON M3C 1L9 Tel: 800-567-3331 or …
AlertHealth professional risk communication | 2008-05-15
Archived – Updated Safety Information Announced in Canada for Patients Taking TOPAMAX (Topiramate) Regarding Higher than Normal Blood Acid Levels – Janssen-Ortho Inc. – For the Public
… RA-19000220 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … than Normal Blood Acid Levels Toronto, January 20, 2004 - Janssen-Ortho, following discussions with Health Canada, is … ensure that they are aware of this new safety information. Janssen-Ortho is working with Health Canada to update the …
AlertHealth professional risk communication | 2004-01-26
Recall of certain hand sanitizers that may pose health risks (Part 1 - June 17, 2020 to March 24, 2021)
… and have health concerns To help limit the spread of COVID-19, wash your hands often with soap and water for at least 20 … (DIN) but have been accepted for use in Canada during the COVID-19 pandemic Report any health product adverse events …
AlertPublic advisory | 2021-03-24